eedq has been researched along with morphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takano, Y; Yaksh, TL | 1 |
| Gabilondo, AM; García-Sevilla, JA | 1 |
2 other study(ies) available for eedq and morphine
| Article | Year |
|---|---|
Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible antagonist.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Dose-Response Relationship, Drug; Imidazoles; Injections, Spinal; Male; Medetomidine; Morphine; Quinolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Spinal Cord | 1991 |
Spontaneous withdrawal from long-term treatment with morphine accelerates the turnover of alpha 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebral Cortex; Clonidine; Male; Morphine; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Substance Withdrawal Syndrome; Time Factors; Up-Regulation | 1995 |